Species differences in susceptibility to the gastro-ulcerogenic action of anti-inflammatory agents.
D000284:Administration, Oral; D000557:Ambystoma; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000188:drug therapy; D005260:Female; D005399:Fishes; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D006168:Guinea Pigs; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D010653:Phenylbutazone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D011784:Quail; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013276:Stomach Ulcer / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D005439:Flufenamic Acid; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D007213:Indomethacin